Agilent Technologies (A) Common Equity (2009 - 2026)
Agilent Technologies (A) posted quarterly Common Equity of -$202.0 million for Q2 2026, down 103.29% year-over-year from $6.1 billion in Q2 2025, and down 102.92% quarter-over-quarter from $6.9 billion in Q1 2026.
Agilent Technologies (A) Common Equity (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Common Equity for 18 consecutive years, with -$202.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Common Equity fell 103.29% year-over-year to -$202.0 million; the TTM figure through Apr 2026 stood at -$202.0 million (down 103.29% YoY), while the FY2025 annual figure was -$226.0 million, down 104.15% from the prior year.
- Common Equity eased to -$202.0 million in Q2 2026 per A's latest filing, from $6.9 billion in the prior quarter.
- Across five years, Common Equity topped out at $6.9 billion in Q1 2026 and bottomed at -$327.0 million in Q4 2023.
- Historically, Common Equity has averaged $4.7 billion across 5 years, with a median of $5.4 billion in 2023.
- Annual changes were most pronounced in 2023 — Common Equity plunged 106.16% — and 2024, when it jumped 1766.67%.
- Agilent Technologies' Common Equity stood at $5.3 billion in 2022, then slumped by 106.16% to -$327.0 million in 2023, then surged by 1766.67% to $5.4 billion in 2024, then plunged by 104.15% to -$226.0 million in 2025, then climbed by 10.62% to -$202.0 million in 2026.
- Business Quant data shows A's Common Equity at -$202.0 million in Q2 2026, $6.9 billion in Q1 2026, and -$226.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 52.69 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 52.59 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 1.82 Bn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 7.12 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 6.30 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.61 Bn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 2.84 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 12.82 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.61 Bn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 7.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 7.12 Bn |
| Jan 31, 2026 | 6.91 Bn |
| Oct 31, 2025 | 6.74 Bn |
| Jul 31, 2025 | 6.37 Bn |
| Apr 30, 2025 | 6.14 Bn |
| Jan 31, 2025 | 6.03 Bn |
| Oct 31, 2024 | 5.90 Bn |
| Jul 31, 2024 | 5.90 Bn |
| Apr 30, 2024 | 6.21 Bn |
| Jan 31, 2024 | 6.19 Bn |
| Oct 31, 2023 | -327.00 Mn |
| Jul 31, 2023 | 5.56 Bn |
| Apr 30, 2023 | 5.78 Bn |
| Jan 31, 2023 | 5.61 Bn |
| Oct 31, 2022 | 5.33 Bn |
| Jul 31, 2022 | 5.31 Bn |
| Apr 30, 2022 | 5.29 Bn |
| Jan 31, 2022 | 5.29 Bn |
| Oct 31, 2021 | 5.39 Bn |
| Jul 31, 2021 | 5.31 Bn |